Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RABIES VACCINE INDUSTRY
2.1 Summary about Rabies Vaccine Industry
2.2 Rabies Vaccine Market Trends
2.2.1 Rabies Vaccine Production & Consumption Trends
2.2.2 Rabies Vaccine Demand Structure Trends
2.3 Rabies Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Vero cell rabies vaccine
4.2.2 BHK
4.2.3 Chick embryo cell rabies vaccine
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pre-exposure Prophylaxis
4.3.2 Post-exposure Prophylaxis
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Vero cell rabies vaccine
5.2.2 BHK
5.2.3 Chick embryo cell rabies vaccine
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pre-exposure Prophylaxis
5.3.2 Post-exposure Prophylaxis
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Vero cell rabies vaccine
6.2.2 BHK
6.2.3 Chick embryo cell rabies vaccine
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pre-exposure Prophylaxis
6.3.2 Post-exposure Prophylaxis
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Vero cell rabies vaccine
7.2.2 BHK
7.2.3 Chick embryo cell rabies vaccine
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pre-exposure Prophylaxis
7.3.2 Post-exposure Prophylaxis
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Vero cell rabies vaccine
8.2.2 BHK
8.2.3 Chick embryo cell rabies vaccine
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pre-exposure Prophylaxis
8.3.2 Post-exposure Prophylaxis
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Vero cell rabies vaccine
9.2.2 BHK
9.2.3 Chick embryo cell rabies vaccine
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pre-exposure Prophylaxis
9.3.2 Post-exposure Prophylaxis
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sanofi-Pasteur
10.1.2 GSK (Novartis)
10.1.3 Chengda
10.1.4 Yisheng
10.1.5 Prcmise
10.1.6 VACN
10.1.7 Changsheng
10.1.8 BCHT
10.1.9 Hissen
10.2 Rabies Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 Sanofi-Pasteur
10.2.2 GSK (Novartis)
10.2.3 Chengda
10.2.4 Yisheng
10.2.5 Prcmise
10.2.6 VACN
10.2.7 Changsheng
10.2.8 BCHT
10.2.9 Hissen
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Rabies Vaccine Product Type Overview
2.Table Rabies Vaccine Product Type Market Share List
3.Table Rabies Vaccine Product Type of Major Players
4.Table Brief Introduction of Sanofi-Pasteur
5.Table Brief Introduction of GSK (Novartis)
6.Table Brief Introduction of Chengda
7.Table Brief Introduction of Yisheng
8.Table Brief Introduction of Prcmise
9.Table Brief Introduction of VACN
10.Table Brief Introduction of Changsheng
11.Table Brief Introduction of BCHT
12.Table Brief Introduction of Hissen
13.Table Products & Services of Sanofi-Pasteur
14.Table Products & Services of GSK (Novartis)
15.Table Products & Services of Chengda
16.Table Products & Services of Yisheng
17.Table Products & Services of Prcmise
18.Table Products & Services of VACN
19.Table Products & Services of Changsheng
20.Table Products & Services of BCHT
21.Table Products & Services of Hissen
22.Table Market Distribution of Major Players
23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
25.Table Global Rabies Vaccine Market Forecast (Million USD) by Region 2021f-2026f
26.Table Global Rabies Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f
27.Table Global Rabies Vaccine Market Forecast (Million USD) by Demand 2021f-2026f
28.Table Global Rabies Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f